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Significance 
The commonly-used physical representations of a 
molecule’s structure do not directly indicate its 
biological properties. For the most part, desirable 
pharmacological effects result from non-covalent 
binding to a target protein; unwanted side effects 
may arise from cross-reactivity with other pro- 
teins. A characteristic affinity fingerprint for a 
particular molecule can be generated by assaying 
its pattern of affinities towards a standardized 
panel of proteins, chosen to be highly indepen- 
dent in their binding properties. The fingerprint 
can be used to estimate cross-reactivity more 
generally, creating a new approach to estimating 
toxicity early in the drug design process. 
In its simplest application, this approach to 
chemical classification provides an objective and 
quantitative means of assessing functional diver- 
sity of chemical libraries that is independent of 
current methods, which are based on analysis of 
structural formulae. It should therefore be useful 
in selecting well-diversified core screening sets 
from conventional chemical libraries, allowing 
the existing limited quantities that exist for most 
compounds to be conserved for follow-up 
screening. It also provides a means to guide 
combinatorial chemistry efforts towards con- 
struction of libraries that provide high diversity, 
not just large numbers. 
Because the use of affinity fingerprints to con- 
struct computational surrogates of target proteins 
has proven useful for predicting binding of com- 
pounds with a very wide range of structures, it 
should be feasible to ‘translate’ products of com- 
binatorial chemistry, including peptides, into 
small organic molecules with desirable properties 
for use as human therapeutics. 
The inherent etticiency of afftnity fingerprinting 
expands the scope of approachable drug targets by 
drastically reducing the number of direct assays of 
the target’s biological activity needed to discover 
productive leads. This is particularly important 
when the target protein has not been purified to 
homogeneity, is unstable or is otherwise not avail- 
able in adequate quantities for large scale screen- 
ing, or when the assay procedure is complex and 
costly, as is the case for targets relevant to many of 
the major unmet medical needs. 
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